Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Push up the plunger to expel almost all the air (fig
one Phase II skin trial Evidence gap / no head-to-head or combination RCT exists as of 2025 Typical sermorelin dose / 200-500 mcg subcutaneous injection at bedtime Typical GHK-Cu dose / 1-2 mg subcutaneous or topical, 5 days per week Regulatory status / sermorelin: FDA-approved (NDA 19-559, withdrawn 2008 for commercial reasons)
Each order includes the sealed product container and a batch-specific Certificate of Analysis (COA) verifying identity and purity by HPLC and LCMS
It may also support the gut-brain axis by influencing neurochemical pathways and promoting communication between the gastrointestinal tract and central nervous system (CNS)
This statement, published in the peer-reviewed Journal of Endocrinology and Metabolism, represents the consensus finding across all six trials and nearly 900 participants
